— Know what they know.
Not Investment Advice
Also trades as: CDIOW (NASDAQ) · $vol 0M

CDIO NASDAQ

Cardio Diagnostics Holdings, Inc.
1W: +0.5% 1M: +6.5% 3M: -1.5% YTD: -31.0% 1Y: -54.0% 3Y: -82.2%
$1.96
+0.04 (+2.08%)
 
Weekly Expected Move ±6.3%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 41 · $5.8M mcap · 3M float · 2.00% daily turnover · Short 27% of daily vol
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.8M
52W Range0.97-7.91
Volume26,123
Avg Volume56,705
Beta2.23
Dividend—
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOMeeshanthini V. Dogan
Employees15
SectorHealthcare
IndustryBiotechnology
IPO Date2022-01-14
Websitecdio.ai
311 West Superior Street
Chicago, IL 60654
US
855 226 9991
About Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.

Recent Insider Trades

NameTypeSharesPriceDate
Burton Paul Frederic A-Award 3,286 $1.90 2026-09-30
Betts Wendy J A-Award 3,286 $1.90 2026-09-30
Fung Peter K A-Award 3,286 $1.90 2026-09-30
Intrater James A-Award 3,286 $1.90 2026-09-30
Fung Peter K A-Award 2,854 $2.19 2026-06-30

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms